Grifols SA (GRFS)
8.11
-0.08
(-0.98%)
USD |
NASDAQ |
May 21, 16:00
8.10
-0.01
(-0.12%)
After-Hours: 19:59
Grifols Research and Development Expense (TTM) : 471.52M for March 31, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Cellectis SA | 80.74M |
| Biodexa Pharmaceuticals Plc | 5.234M |
| Amarin Corp. Plc | 16.24M |
| Akari Therapeutics Plc | 3.464M |
| NuCana Plc | 19.05M |